स्पूतनिक वी (Hindi Wikipedia)

Analysis of information sources in references of the Wikipedia article "स्पूतनिक वी" in Hindi language version.

refsWebsite

Global rank Hindi rank

6nih.gov

4^th place

7^th place

4doi.org

2^nd place

5^th place

1nature.com

234^th place

288^th place

1sciencemag.org

857^th place

733^rd place

1youtube.com

9^th place

54^th place

1cnbc.com

220^th place

714^th place

1nytimes.com

7^th place

49^th place

cnbc.com

"Scientists worry whether Russia's Sputnik V' coronavirus vaccine is safe and effective". CNBC. 11 August 2020. अभिगमन तिथि: 11 August 2020.

doi.org

Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. डीओआई:10.1038/d41586-020-02386-2. पीएमआईडी 32782400. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "nature" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL (September 2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". Lancet. 396 (10255): 887–897. डीओआई:10.1016/S0140-6736(20)31866-3. पीएमसी 7471804. पीएमआईडी 32896291. {{cite journal}}: Unknown parameter |displayauthors= ignored (help)
Mahase E (August 2020). "Covid-19: Russia approves vaccine without large scale testing or published results". BMJ. 370: m3205. डीओआई:10.1136/bmj.m3205. पीएमआईडी 32816758.
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG (2021-02-02). "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia". The Lancet. 397 (10275): 671–681. डीओआई:10.1016/s0140-6736(21)00234-8. पीएमसी 7852454. पीएमआईडी 33545094. {{cite journal}}: Unknown parameter |displayauthors= ignored (help)

nature.com

Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. डीओआई:10.1038/d41586-020-02386-2. पीएमआईडी 32782400. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "nature" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है

nih.gov

pubmed.ncbi.nlm.nih.gov

Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. डीओआई:10.1038/d41586-020-02386-2. पीएमआईडी 32782400. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "nature" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL (September 2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". Lancet. 396 (10255): 887–897. डीओआई:10.1016/S0140-6736(20)31866-3. पीएमसी 7471804. पीएमआईडी 32896291. {{cite journal}}: Unknown parameter |displayauthors= ignored (help)
Mahase E (August 2020). "Covid-19: Russia approves vaccine without large scale testing or published results". BMJ. 370: m3205. डीओआई:10.1136/bmj.m3205. पीएमआईडी 32816758.
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG (2021-02-02). "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia". The Lancet. 397 (10275): 671–681. डीओआई:10.1016/s0140-6736(21)00234-8. पीएमसी 7852454. पीएमआईडी 33545094. {{cite journal}}: Unknown parameter |displayauthors= ignored (help)

ncbi.nlm.nih.gov

Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL (September 2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". Lancet. 396 (10255): 887–897. डीओआई:10.1016/S0140-6736(20)31866-3. पीएमसी 7471804. पीएमआईडी 32896291. {{cite journal}}: Unknown parameter |displayauthors= ignored (help)
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG (2021-02-02). "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia". The Lancet. 397 (10275): 671–681. डीओआई:10.1016/s0140-6736(21)00234-8. पीएमसी 7852454. पीएमआईडी 33545094. {{cite journal}}: Unknown parameter |displayauthors= ignored (help)

nytimes.com

Kramer, Andrew. "Russia is offering to export hundreds of millions of vaccine doses, but can it deliver?". The New York Times. अभिगमन तिथि: 20 February 2021.

sciencemag.org

"Russia's approval of a COVID-19 vaccine is less than meets the press release". Science. 11 August 2020. अभिगमन तिथि: 13 August 2020. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "cohen" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है

youtube.com

How Sputnik V works, Gamaleya Research Institute of Epidemiology and Microbiology, 2021-01-11, अभिगमन तिथि: 2021-03-18